UNCO THERAPEUTICS LLC

Biotech · Private

PAR2-targeted small molecule antagonists for chronic pain treatment

Grants
$350K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of Allosteric Uncouplers as Therapeutics for Chronic Pain$350,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3373Akston Biosciences Corp—$17M
3374Aqualung Therapeutics Corp.—$3.1M
3375Concerto Biosciences, Inc.—$16M
3376UNCO THERAPEUTICS LLC——
3377Inspira Therapeutics, Inc——
3378SYGNAMAP, INC.——
3379Polyrizon Ltd.—$7.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.